Oxidative stress as a treatment target in atopic dermatitis: The role of furfuryl palmitate in mild-to-moderate atopic dermatitis
- PMID: 33015298
- PMCID: PMC7522904
- DOI: 10.1016/j.ijwd.2020.03.042
Oxidative stress as a treatment target in atopic dermatitis: The role of furfuryl palmitate in mild-to-moderate atopic dermatitis
Keywords: Atopic dermatitis; ECZEMA; Furfuryl palmitate; Oxidative stress; Treatment.
Figures


Similar articles
-
Real-World Evidence of an Emollient Device for Atopic and Contact Dermatitis in Pediatric to Adult Patients - Data from a Post-Marketing Surveillance.Clin Cosmet Investig Dermatol. 2022 Sep 7;15:1797-1803. doi: 10.2147/CCID.S364934. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36101562 Free PMC article.
-
Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders.Dermatol Ther (Heidelb). 2018 Sep;8(3):339-347. doi: 10.1007/s13555-018-0239-0. Epub 2018 May 22. Dermatol Ther (Heidelb). 2018. PMID: 29790104 Free PMC article. Review.
-
Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study.J Investig Allergol Clin Immunol. 2009;19(3):204-9. J Investig Allergol Clin Immunol. 2009. PMID: 19610263 Clinical Trial.
-
[Experimental survey of a new topical anti-oxidant based on furfuryl palmitate in the treatment of child's and baby's dermatitis with eczema: results from a multicenter clinical investigation].Minerva Pediatr. 2002 Oct;54(5):465-74. Minerva Pediatr. 2002. PMID: 12244285 Clinical Trial. Italian.
-
Hand eczema and long-term prognosis in atopic dermatitis.Acta Derm Venereol Suppl (Stockh). 1985;117:1-59. Acta Derm Venereol Suppl (Stockh). 1985. PMID: 2931938 Review.
Cited by
-
Phytocannabinoids in the Pharmacotherapy of Psoriasis.Molecules. 2023 Jan 25;28(3):1192. doi: 10.3390/molecules28031192. Molecules. 2023. PMID: 36770858 Free PMC article. Review.
-
A New Prescription Emollient Device (PED) For Psoriasis of Sensitive Areas and Folds: A Randomized Prospective Open Trial.Psoriasis (Auckl). 2024 Nov 15;14:135-142. doi: 10.2147/PTT.S465545. eCollection 2024. Psoriasis (Auckl). 2024. PMID: 39564575 Free PMC article.
-
Efficacy and Safety of an Antioxidant-Enriched Medical Device for Topical Use in Adults with Eczematous Dermatitis.Dermatol Ther (Heidelb). 2022 Apr;12(4):1015-1025. doi: 10.1007/s13555-022-00705-1. Epub 2022 Apr 7. Dermatol Ther (Heidelb). 2022. PMID: 35389183 Free PMC article.
-
Real-World Evidence of an Emollient Device for Atopic and Contact Dermatitis in Pediatric to Adult Patients - Data from a Post-Marketing Surveillance.Clin Cosmet Investig Dermatol. 2022 Sep 7;15:1797-1803. doi: 10.2147/CCID.S364934. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36101562 Free PMC article.
-
Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide.Int J Mol Sci. 2021 Feb 6;22(4):1642. doi: 10.3390/ijms22041642. Int J Mol Sci. 2021. PMID: 33561995 Free PMC article.
References
-
- Bocchietto E., Pecis L., Lisi P. Furfuril palmitato: Un nuovo antiossidante topico efficace nel trattamento di dermatiti eczematose. G Ital di Dermatologia e Venereol. 2002;137(2):1–13.
-
- Lauriola M, Pigatto P, Pedrelli V. A single-center, randomized, perspective, investigator blinded controlled trial to examine efficacy and safety of a furpalmate cream in comparison to topical corticosteroid in atopic dermatitis of hands of 40 adult patients. In: Poster session 20th EADV Congress. Lisbon, Portugal; 2011.
-
- Man G., Elias P.M., Man M.Q. Therapeutic benefits of enhancing permeability barrier for atopic eczema. Dermatol Sin. 2015;33(2):84–89.
LinkOut - more resources
Full Text Sources